Increased expression of IGF-1 and IGF1R in PDAC is closely associated with unfavorable clinical outcomes, with elevated levels correlating with poor survival rates and higher tumor grades, establishing them as prognostic indicators for pancreatic cancer patients (111). This evidence concerns the gene IGF1R and familial pancreatic carcinoma.